VRTX
Vertex Pharmaceuticals
$479.00
+$1.62 (+0.34%)Jul 27, 2026
Key metrics
The numbers that frame VRTX today
- Market cap
- $121.57B
- P/E (TTM)
- 28.0
- EV / FCF
- 31.8
- Gross margin
- 86.2%
- EV / Sales
- 9.7
- ROIC
- 31.7%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $362.50
- 52wk High
- $531.86
Growth
Revenue and earnings trend for VRTX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about VRTX
Is Vertex Pharmaceuticals a good buy?
Yes. Vertex Pharmaceuticals has excellent quality and strong momentum. Both signals support the setup. Growth looks strong, which supports the long-term business case. We think Vertex Pharmaceuticals is selling at a fair price.
What is the market capitalization of VRTX?
Vertex Pharmaceuticals's market capitalization is $121.57B.
What is the P/E ratio for VRTX stock?
Vertex Pharmaceuticals's current P/E ratio is 28.
What is the 52-week high for VRTX stock?
The 52-week high for Vertex Pharmaceuticals is $531.86. The current close of $479.00 is 9.9% below that high.
What is the 52-week low for VRTX stock?
The 52-week low for Vertex Pharmaceuticals is $362.50. The current close of $479.00 is 32.1% above that low.
Does VRTX stock pay dividends?
Vertex Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for VRTX?
Vertex Pharmaceuticals's Debt / Equity ratio is 0.1.